Inulin is one of the best-studied prebiotic fibers. Its most dependable effects are increasing beneficial gut bacteria, improving regularity, and boosting calcium and magnesium absorption. It modestly lowers cholesterol and triglycerides, supports small reductions in weight, and improves blood sugar in people with diabetes. Gains are largest in those carrying extra weight or metabolic problems. Gas and bloating are common. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | < 100 mg/dL (lower if high cardiovascular risk) | Tracks the main lipid benefit of inulin |
| Triglycerides | < 100 mg/dL (conventional < 150 mg/dL) | Captures the triglyceride-lowering effect |
| Fasting glucose | 75–90 mg/dL (conventional < 100 mg/dL) | Detects glucose benefit, mainly in dysglycemia |
| Fasting insulin | < 8 µU/mL (lower–normal preferred) | Most responsive metabolic marker in diabetes subgroup |
| hs-CRP | < 1.0 mg/L | Gauges any anti-inflammatory effect |
Cadence: Baseline before starting; ~8–12 weeks after reaching target dose, then every 6–12 months.